Acute Pancreatitis
Acute Pancreatitis
болезней
              ACUTE
           PANCREATITIS
             Clinical anatomy
●Pan – all , creas - meat (all of the meat). The
 pancreas develops from three rudiments: two
 ventral and one dorsal. At 4-5 weeks of fetal
 development, there is already a close
 relationship with duodenum and choledoch. Lies
 behind the stomach at L1 - L2. Length 15-23 cm,
 height - 3-6 cm, weight 70-150 g. Isolated head
 with hook-shaped process, neck, body and tail.
●No clear capsule.
       ACUTE PANCREATITIS
●The incidence of acute pancreatitis (AP)
 has increased during the past 20 years.
 Most patients develop a mild and self-
 limited course; however, 10% to 20% of
 patients have a rapidly progressive
 inflammatory response associated with
 prolonged length of hospital stay and
 significant morbidity and mortality.
 Patients with mild pancreatitis have a
 mortality rate of less than 1%, but in severe
 pancreatitis, this increases up to 10% to
      ACUTE PANCREATITIS
●The most common cause of death in this
 group of patients is multiorgan dysfunction
 syndrome. Mortality in pancreatitis has a
 bimodal distribution; in the first 2 weeks,
 also known as the early phase, the
 multiorgan dysfunction syndrome is the
 final result of an intense inflammatory
 cascade triggered initially by pancreatic
 inflammation. Mortality after 2 weeks, also
 known as the late period, is often caused
 by septic complications.
               Definition
Acute pancreatitis is initially an aseptic
inflammation of the pancreas, in which it is
possible to damage the surrounding tissues
and distant organs, as well as systems.
THE MAIN COMPONENTS OF THE ACUTE
     DESTRUCTIVE PANCREATITIS
                   ACTUALLY
                  PANCREATITIS
    PERITONITIS            PARAPANCREATITIS
        Relevance of the problem
● The increase in the incidence rate (from 47 to 238
  people per 1 million population per year) with a steady
  trend towards growth and the proportion of severe
  forms of AP.
● The overall case fatality rate from 4.5-15%, in
  destructive forms of 24-60%
● In 73% of patients after pancreatic necrosis there is a
  persistent disability.
● The peak incidence of patients with acute pancreatitis
  falls on persons of active working age 30-50 years.
● The duration of inpatient treatment is on average 65
  days.
                      Etiology
● AP as an independent disease is polietiologic, but
  monopatogenetic disease.
● Any reason that causes hypersecretion of pancreatic
  juice and obstruction of its outflow with the
  development of hypertension in the pancreatic ducts,
  cast in the ducts of the cytotoxic and activation of
  pancreatic enzymes substances, direct damage
  pancreatitits, can lead to the development of AP.
                         Etiology
● 1. Acute alcohol-alimentary pancreatitis– 55% .
● 2. Acute biliary pancreatitis (occurs due to bile reflux
  in the pancreatic ducts in biliary hypertension, which
  occurs, as a rule, due to cholelithiasis, sometimes –
  from other causes: diverticula, papillitis, opisthorchiasis,
  etc.)– 35%.
● 3. Acute traumatic pancreatitis (due to pancreatic
  injury, including operating room or after ENDOSCOPIC
  RETROGRADE CHOLANGIOPANCREATOGRAPHY ERCP)
  -2 – 4 %.
                     Etiology
4. Other etiological forms of causes: autoimmune
processes, vascular insufficiency, vasculitis,
medications (hydrochlorothiazide, steroid and non-
steroid hormones, mercaptopurine), infectious diseases
(viral mumps, hepatitis, cytomegalovirus), allergic
factors (varnishes, paints, smells of building materials,
anaphylactic shock), hormonal processes during
pregnancy and menopause, diseases of the nearby
organs (gastro, penetrating ulcer, tumors of the
hepatopancreatoduodenal region) – 6 – 8%.
●Gallstones and ethanol abuse account for
 70% to 80% of AP cases.
●In pediatric patients, abdominal blunt
 trauma and systemic diseases are the two
 most common conditions that lead to
 pancreatitis.
                      Pathogenesis
● The combination of several triggering factors becomes the
  impetus for the initial intraacinar activation of proteolytic
  enzymes and pancreatic autolysis.
● Primary factors of aggression :
   а) pancreatic enzymes: trypsin, chymotrypsin, cause
   proteolysis of tissue proteins.
   б) phospholipase destroys cell membranes.
   в) lipase hydrolyses intracellular triglycerides to fatty acids and,
   connecting with calcium, leads to lipolytic necrosis in the
   pancreas, retroperitoneal tissue and mesentery of the small
   and large intestine.
   г) elastase destroys vessel walls and inter-tissue connective
   tissue structures, which leads to necrosis.
● Active enzymes begins to act locally and goes beyond the
  pancreas parenchyma, getting on the portal system in the liver,
  lymphatic system in the circulating blood.
                  Pathogenesis
● After entering the blood of pancreatic enzymes, the
  kallikrein-kinin system is activated with the formation
  and release of secondary aggression factors - free
  kinins (bradykinin, histamine and serotonin).
● It is the activation of kinins that manifests itself as a
  pain syndrome and leads to an increase in vascular
  permeability with the formation of extensive tissue
  edema, peritoneal exudation and thrombohemorrhagic
  changes.
● Active phospholipase stimulates the production of
  prostaglandins substances that enhance the secretory
  activity of pancreas.
               Pathogenesis
●The factors of the aggression of the third order
 is the importance of cytokines ( interleukin 1, 6
 and 8, tumor necrosis factor, platelet-activating
 factor, prostaglandins, thromboxane,
 leukotrienes, nitric oxide), which is produced by
 macrophages, mononuclear cells, neutrophils on
 the background of microcirculatory disorders,
 hypoxia.
                  Pathogenesis
● Cytokines, enzymes, metabolites of different nature,
  formed in the pancreas, adipose tissue, intestinal wall,
  abdominal cavity increase the permeability of the
  intestinal wall, there is a translocation of intestinal
  flora, contribute to the flow of toxins into the portal and
  systemic blood flow and lymphatic bed with the defeat
  of target organs: liver, lungs, kidneys, heart, brain,
  gastric and intestinal mucosa.
● Factors of aggression and organ dysfunction create a
  syndrome of mutual aggravation.
     Atlanta Criteria for Acute
           Pancreatitis
●In 1992, the International Symposium on
 Acute Pancreatitis defined severe
 pancreatitis as the presence of local
 pancreatic complications (necrosis,
 abscess, or pseudocyst) or any evidence of
 organ failure. Severe pancreatitis is
 diagnosed if there is any evidence of organ
 failure or a local pancreatic complication.
     Atlanta Criteria for Acute
           Pancreatitis
Systemic Complications
● Disseminated intravascular coagulation
 (platelet count ≤100,000)
● Fibrinogen <1 g/liter
● Fibrin split products >80 μg/dL
● Metabolic disturbance (calcium level ≤7.5
 mg/dL)
     Atlanta Criteria for Acute
           Pancreatitis
Local Complications
●Necrosis
●Abscess
●Pseudocyst
Severe pancreatitis is defined by the
  presence of any evidence of organ failure
  or a local complication
    Atlanta Criteria for Acute
          Pancreatitis
Organ Failure, as Defined by
● Shock (systolic blood pressure <90 mm
 Hg)
●Pulmonary insufficiency (Pao2 <60 mm Hg)
●Renal failure (creatinine level >2 mg/dL
 after fluid resuscitation)
●Gastrointestinal bleeding (>500 mL/24 hr)
● Acute pancreatitis
easy
heavy
● Sharp liquid formations
● Pancreatonecrosis
 Sterile pancreatic necrosis
 Infected pancreatic necrosis
Acute pseudocyst
Pancreatic abscess
       Classification of the Russian
       society of surgeons– 2014г
● 1. Mild acute pancreatitis. Pancreonecrosis in this form of
  acute pancreatitis is not formed (edematous pancreatitis) and
  organ failure does not develop.
● 2. Acute pancreatitis of medium degree. It is characterized by
  the presence of either one of the local manifestations of the
  disease: peripancreatic infiltrate, pseudocyst, borderline
  infected pancreonecrosis (abscess) - or/and the development
  of common manifestations in the form of transient organ
  failure (no more than 48 hours).
● 3. Severe acute pancreatitis. It is characterized by the presence
  of either unlimited infected pancreonecrosis (purulent necrotic
  parapancreatitis), or/and the development of persistent organ
  failure (more than 48 hours).
      Phases of acute pancreatitis
● Edematous (interstitial) pancreatitis in frequency is
  80-85% in the structure of the disease. It is
  characterized by a mild severity of the disease and the
  rare development of local complications or systemic
  disorders, the phase course does not have.
● Necrotic pancreatitis (pancreonecrosis) occurs in
  15-20% of patients, is always clinically manifested by
  an average or severe degree of the disease, has a
  phase course of the disease with two peaks of
  mortality – early and late. After the early phase, which
  usually lasts for the first two weeks, followed by a
  second or later phase, which can be delayed for a
  period of weeks to months.
      Phases of acute pancreatitis
● Phase I – early, in turn, is divided into two periods :
● - Phase IA is usually the first week of the disease.
  During this period, there is the formation of necrosis
  foci in the pancreatic parenchyma or the surrounding
  tissue of various volumes and the development of
  endotoxicosis. Endotoxicosis is manifested by light or
  deep systemic disorders in the form of organ (multi-
  organ) insufficiency. The maximum period of necrosis
  formation in the pancreas is usually three days, after
  this period it does not progress in the future. However,
  in severe pancreatitis, the period of its formation is
  much less (usually 24-36 hours).
      Phases of acute pancreatitis
IА phase,
In the abdominal cavity there is an accumulation of
  enzymatic effusion (enzymatic peritonitis and
  parapancreatitis), which is one of the sources of
  endotoxicosis. The average severity of the disease is
  manifested by transient dysfunction of individual
  organs or systems. In severe forms of the disease in
  the clinical picture may be dominated by the
  phenomenon of organ (multi-organ) failure:
  cardiovascular, respiratory, renal, hepatic, etc.
     Phases of acute pancreatitis
● I В phase, as a rule, the second week of the
 disease. Is characterized by the body's reaction
 to the formed foci of necrosis (as in pancreas
 and parapancreatic tissue). Clinically prevalent
 phenomenon resorptive fever, is formed
 peripancreatic infiltration.
       Phases of acute pancreatitis
● Phase II – late, sequestration phase (usually begins
 with the 3rd week of the disease, can last several
 months). Sequesters in the pancreas and
 retroperitoneal tissue usually begin to form from the
 14th day of the onset of the disease. With the rejection
 of large fragments of necrotic pancreatic tissue,
 depressurization of its ductal system and the
 formation of an internal pancreatic fistula can occur.
 Two variants of this phase flow are possible
● · aseptic sequestration
● · septic sequestration - infected pancreonecrosis, which may
  be limited (abscess) or undivided (purulent necrotic
  parapancreatitis).
                        symptoms
● Clinical manifestations depend on morphological form,
  presence or absence of functional disorders and organic
  complications.
                          Pain syndrome
● Direct symptoms
focal hypoechoic area in the parenchyma
   ACUTE INTERSTITIAL PANCREATITIS
           1 variant – 32-35%
3. Treatment
             Computer tomography
● Computer tomography it is the most sensitive method of
  research (71-100%) in acute pancreatitis and its complications,
  giving comprehensive information about the state of the
  pancreas and retroperitoneal space, involvement in the process
  of biliary tract, adjacent vascular structures and gastrointestinal
  tract.
● Contrast CT (pancreatic angiography) it allows to diagnose the
  presence of pancreatic necrosis with high accuracy, to assess
  its scale and localization, to identify a variety of angiogenic
  complications (pancreatic and parapancreatic vessels, the
  formation of pseudoaneurysms, occlusion of the portal vein
  branches).
●Contrast-enhanced computed tomography
 (CT) is currently the best modality for
 evaluation of the pancreas, especially if the
 study is performed with a multidetector CT
 scanner.
●The most valuable contrast phase in which
 to evaluate the pancreatic parenchyma is
 the portal venous phase (65 to 70 seconds
 after injection of contrast material), which
 allows evaluation of the viability of the
 pancreatic parenchyma, amount of
 peripancreatic inflammation, and presence
 of intra-abdominal free air or fluid
 collections.
●Noncontrast CT scanning may also be of
 value in the setting of renal failure by
 identifying fluid collections or extraluminal
 air.
●Using imaging characteristics, Balthazar
 and associates have established the CT
 severity index. This index correlates CT
 findings with the patient’s outcome.
 Computed Tomography Severity
Index (CTSI) for Acute Pancreatitis
●FEATURE                        POINTS
 Pancreatic Inflammation
 Normal pancreas                       0
 Focal or diffuse pancreatic enlargement 1
 Intrinsic pancreatic alterations with
 peripancreatic fat inflammatory changes
 2 Single fluid collection or phlegmon
 3 Two or more fluid collections or gas, in or
 adjacent to the pancreas                4
 Computed Tomography Severity
Index (CTSI) for Acute Pancreatitis
●FEATURE                POINTS
 Pancreatic Necrosis
None                      0
≤30%                      2
30%-50%                   4
>50%                      6
 Computed Tomography Severity
Index (CTSI) for Acute Pancreatitis
●CTSI 0-3, mortality 3%, morbidity 8%; CTSI
 4-6, mortality 6%, morbidity 35%; CTSI 7-10,
 mortality 17%, morbidity 92%.
Parapancreatic necrotic phlegmon
Spread of phlegmon (right and left)
●Abdominal magnetic resonance imaging
 (MRI) is also useful to evaluate the extent
 of necrosis, inflammation, and presence of
 free fluid. However, its cost and availability
 and the fact that patients requiring imaging
 are critically ill and need to be in intensive
 care units limit its applicability in the acute
 phase.
●Although magnetic resonance
 cholangiopancreatography (MRCP) is not
 indicated in the acute setting of AP, it has an
 important role in the evaluation of patients with
 unexplained or recurrent pancreatitis because it
 allows complete visualization of the biliary and
 pancreatic duct anatomy. In addition,
 intravenous (IV) administration of secretin
 increases pancreatic duct secretion, which
 causes a transient distention of the pancreatic
 duct.
          Endoscopic diagnosis
●Endoscopic retrograde cholangiography (ERCP)
 and endoscopic papillotomy is indicated for
 biliary pancreatitis with mechanical icterus and/
 or cholangitis, taking into account the
 visualization of the enlarged diameter of the
 common bile duct according to ultrasound and
 the inefficiency of complex conservative therapy
 for 48 hours.
●In the setting of gallstone pancreatitis,
 endoscopic ultrasound (EUS) may play an
 important role in the evaluation of
 persistent choledocholithiasis. Several
 studies have shown that routine ERCP for
 suspected gallstone pancreatitis reveals no
 evidence of persistent obstruction in most
 cases and may actually worsen symptoms
 because of manipulation of the gland.
●EUS has been proven to be sensitive for
 identifying choledocholithiasis; it allows
 examination of the biliary tree and
 pancreas with no risk of worsening of the
 pancreatitis. In patients in whom persistent
 choledocholithiasis is confirmed by EUS,
 ERCP can be used selectively as a
 therapeutic measure.
Performing endoscopic papillosphincterotomy
             with wedged stone
             Differential diagnosis
● Differential diagnosis of AP at the prehospital stage is
  carried out with the following diseases :
● – with the syndrome of acute inflammation (acute
  appendicitis, cholecystitis, etc.);
● – with the syndrome perforation of a hollow organ in
  the free abdominal cavity (perforated gastroduodenal
  ulcer, perforation intestinal ulcers);
● – with the syndrome obstruction of the gastrointestinal
  tract (ACUTE INTESTINAL OBSTRUCTION, gastric
  volvulus, etc.);
● – with acute internal bleeding syndrome (ulcerative
  gastroduodenal hemorrhages).
     Assessment of severity of acute
           pancreatitis (AP)
To assess the severity of AP and prognosis of the disease, it is
   possible to use a scale of criteria for primary rapid
   assessment of the severity of acute pancreatitis . The most
   important is the early detection of severe pancreatitis, the
   results of treatment of which are largely due to the period of
   its onset. The presence of at least two signs listed in the
   school of rapid assessment, allows you to diagnose medium-
   severe (severe) AP, which is subject to mandatory referral to
   the intensive care unit. The remaining patients (mild AP) are
   hospitalized in the surgical Department.
    Assessment of Severity of
           Disease
●The earliest scoring system designed to
 evaluate the severity of AP was introduced
 by Ranson and colleagues in 1974. It
 predicts the severity of the disease on the
 basis of 11 parameters obtained at the
 time of admission or 48 hours later. The
 mortality rate of AP directly correlates with
 the number of parameters that are positive.
      Assessment of Severity of
             Disease
●Severe pancreatitis is diagnosed if three or more
 of the Ranson criteria are fulfilled. The main
 disadvantage is that it does not predict the
 severity of disease at the time of the admission
 because six parameters are assessed only after
 48 hours of admission. The Ranson score has a
 low positive predictive value (50%) and high
 negative predictive value (90%). Therefore, it is
 mainly used to rule out severe pancreatitis or to
 predict the risk of mortality.
 Ranson Prognostic Criteria for
  Non-Gallstone Pancreatitis
●At presentation
• Age >55 years
• Blood glucose level >200 mg/dL
• White blood cell count >16,000 cells/mm3
• Lactate dehydrogenase level >350 IU/liter
• Aspartate aminotransferase level >250 IU/
  liter
 Ranson Prognostic Criteria for
  Non-Gallstone Pancreatitis
●After 48 hours of admission
• Hematocrit: decrease >10%
• Serum calcium level <8 mg/dL
• Base deficit >4 mEq/L
• Blood urea nitrogen level: increase >5 mg/dL
• Fluid requirement >6 liters
• PaO2 <60 mm Hg
Ranson score ≥3 defines severe pancreatitis.
 Ranson Prognostic Criteria for
    Gallstone Pancreatitis
●At presentation
• Age >70 years
• Blood glucose level >220 mg/dL
• White blood cell count >18,000 cells/mm3
• Lactate dehydrogenase level >400 IU/liter
• Aspartate aminotransferase level >250 IU/
  liter
 Ranson Prognostic Criteria for
    Gallstone Pancreatitis
●After 48 hours of admission
• Hematocrit*: decrease >10%
• Serum calcium level <8 mg/dL
• Base deficit >5 mEq/L
• Blood urea nitrogen level: increase >2 mg/dL
• Fluid requirement >4 liters
• PaO2: Not available
Ranson score ≥3 defines severe pancreatitis.
    Assessment of Severity of
           Disease
●AP severity can also be addressed by the
 Acute Physiology and Chronic Health
 Evaluation (APACHE II) score. Based on the
 patient’s age, previous health status, and
 12 routine physiologic measurements,
 APACHE II provides a general measure of
 the severity of disease. An APACHE II score
 of 8 or higher defines severe pancreatitis.
    Assessment of Severity of
           Disease
●The main advantage is that it can be used
 on admission and repeated at any time.
 However, it is complex, not specific for AP,
 and based on the patient’s age, which
 easily upgrades the AP severity score.
 APACHE II has a positive predictive value of
 43% and a negative predictive value of 89%.
    Assessment of Severity of
           Disease
●C-reactive protein (CRP) is an inflammatory
 marker that peaks 48 to 72 hours after the
 onset of pancreatitis and correlates with
 the severity of the disease. A CRP level of
 150 mg/mL or higher defines severe
 pancreatitis.
       Assessment of Severity of
              Disease
●The major limitation is that it cannot be used on
 admission; the sensitivity of the assay
 decreases if CRP levels are measured within 48
 hours after the onset of symptoms. In addition
 to CRP, a number of studies have shown other
 biochemical markers (e.g., serum levels of
 procalcitonin, IL-6, IL-1, elastase) that correlate
 with the severity of the disease. However, their
 main limitation is their cost, and they are not
 widely available.
            Prognostic scale to assess the severity of acute pancreatitis
● peritoneal syndrome;
● oliguria (less than 250 ml of urine in the last 12 hours);
● skin symptoms (redness of the face, cyanosis);
● systolic blood pressure less than 100 mm;
● encephalopathy;
● the hemoglobin level of more than 160 g/l;
● the number of leukocytes more than 14 х109/l;
● blood glucose level over 10 mmol/l;
● urea level above 12 mmol/l;
● metabolic disorders according to ECG;
● cherry or brown-black color of enzymatic exudate obtained by laparoscopy (laparocentesis);
● detection by laparoscopy common enzymatic parapancreatitis emerging in the retroperitoneal
  space on the right and left;
● the presence of common fat necrosis, identified by laparoscopy;
● the absence of effect of the basic treatment.
                                             ASSESSMENT
● If a particular patient has at least 5 signs from among the listed, then with 95% probability he
  has a severe form of AP.
● If you have 2-4 symptom – AP of medium degree.
● If there is no sign or there is a maximum of one of them – a light (edematous) form of AP.
                     Treatment
● Most patients suffer from the disease in mild to
  moderate severity and usually recover. Pancreatic
  necrosis is complicated by the 20-30% of cases.
● Drug prevention of pancreatic necrosis is not yet
  possible. “The pancreas is an organ you can't rely on” -
  Zollinger.
● Back in 1894, Korte suggested the priority of surgery in
  the treatment of pancreatitis. But, perhaps, none of the
  urgent disease was not so frequent shifts opposite
  strategies of surgical treatment.
                     Treatment
● Open classical interventions and swab drainage
  inevitably lead to infection of the abdominal cavity and
  retroperitoneal space with severe hospital infection. At
  the same time, the area of infection as a result of
  operations inevitably expands. As a result, the
  detoxifying effect of the operation is quickly replaced
  by the generalization of the infectious process. Further,
  in the early period of the disease, the patient
  experiences a state of endotoxic shock and is more
  vulnerable to surgical aggression.
A single medical concept of pancreatic
           necrosis is absent.
 The thesis about the inexpediency of
    early operations in the phase of
 enzymatic shock or pancreatogenic
    infiltrate in the absence of other
  indications of an emergency nature
          seems to be dominant
               Tactics of treatment
● An active conservative strategy with deferred operations is
  used. Based on a powerful intensive therapy, including
  detoxification, antibiotic therapy, treatment of intestinal
  insufficiency syndrome for relief of translocation of intestinal
  microflora, correction of insufficiency of organs and systems.
● Surgical treatment in this version of the strategy is maximally
  delayed for a long period. This intensive care often avoids local
  and systemic complications. On arrival, patients are treated
  with intensive care.
      Directions of therapy of acute
               pancreatitis
●Tactics and methods of complex treatment of
 destructive pancreatitis are determined by the
 category of severity of the patient's condition.
 Complex treatment of the patient with
 destructive pancreatitis is carried out only in the
 intensive care unit.
●The main directions and methods of complex
 therapy of destructive pancreatitis include
 several sections.
         1. Intensive corrective therapy
COMPENSATION
                      Minimally invasivedrainage
                                                         laparotomy
Sub-COMPENSATION
laparotomy
DECOMPENSATION
            Puncture channel 15 mm
Removal of sequester by
   special extractor
Hooks "Mini-assistant" routinely omental bag
In the packing bag wound up the finished clip
The finished clip removed the sequester
Washing of the omental bag with a
  solution of hydrogen peroxide
Washing of the omental bag with antiseptic
                 solution
Appearance of postoperative wound after
           minilaparotomy
Sequesters removed from the omental bag
           Result of treatment
●The results of treatment of acute pancreatitis
 have stabilized in last years.
●In edematous forms of acute pancreatitis
 outcomes and prognosis are favorable.
 Mortality in sterile pancreatic necrosis ranges
 from 10 to 15%, in infected pancreatic necrosis
 ranges from 40-60% mainly due to purulent-
 septic complications.
Mortality from acute pancreatitis
                      Infected pancreatic
                            necrosis
       Sterile
     pancreatic
      necrosis
                             Late
        Early
          1       2             3    Weeks
The end